Karo Pharma AB Stock
Karo Pharma AB Stock
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Karo Pharma AB.
With a target price of 51 € there is potential for a 837.5% increase which would mean more than doubling the current price of 5.44 € for Karo Pharma AB.
Pros and Cons of Karo Pharma AB in the next few years
Pros
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Karo Pharma AB vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Karo Pharma AB | - | - | - | - | - | - | - |
| Active Biotech AB | 8.110% | 2.564% | -6.977% | -42.857% | -9.091% | -91.011% | -96.947% |
| Medivir AB | -10.320% | -7.482% | 34.663% | 58.198% | 416.471% | -74.514% | -77.967% |
| Immunic Inc. | 4.980% | -11.317% | 11.163% | -5.159% | 122.326% | -30.194% | -92.971% |
Comments
Karooooo (NASDAQ:KARO) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo (NASDAQ:KARO) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "strong-buy" rating.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its "outperform" rating re-affirmed by analysts at Raymond James Financial, Inc.. They now have a $60.00 price target on the stock, up previously from $58.00.
Show more
Ratings data for KARO provided by MarketBeat